Alternatives to En Carta Diagnostics

Revolutionizing genomic analysis with innovative sequencing technology.

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Developing breath-based diagnostics for lung diseases.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing novel immunotherapies and diagnostics for cancer.

AI-powered precision testing for patient identification in clinics and clinical trials.

Cue is a health technology company developing and manufacturing a molecular diagnostic platform for rapid, lab-quality health testing at home.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Developing AI-powered diagnostics for neurodegenerative diseases.

Developing advanced vision restoration technology through a retinal implant.

Developing lightweight bionic technology.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Developing soft, stretchable brain-computer interface platforms.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing novel male contraceptives.

Develops and distributes bioreactor technology for stem cell cultivation.

Developing a new histotripsy therapeutic platform for cancer treatment.

Pioneering Liquid State Intelligence for physical-world AI.

A leading incubator and venture builder in deep tech and life science.

Elevating uterine health through innovative biomaterial therapies.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.

Wearable chip that analyzes proteins and hormones in real time.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Cultivating wood directly into its final shape, 10,000x faster than forestry.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Developing and industrializing cellulose-based superabsorbent materials as a fossil-free and biodegradable alternative.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Integrated life science company specializing in diagnostic testing solutions and life science raw materials.

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

Developing an automated platform for liquid biopsy sample preparation.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

Developing advanced diagnostic technology to expand global access to healthcare.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Precision vaginal microbiome testing and multi-omics for women's health, offering clinically actionable insights and STI testing.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing novel therapeutics to restore gut lymphatic function.